Cecilia Rosso, Eugenio De Corso, Valerio Conti, Letizia Nitro, Alberto Maria Saibene, Elena Parazzini, Rocco Rinaldo, Sabrina De Pascalis, Flavio Arnone, Stefano Centanni, Claudio Montuori, Leandro Maria D'Auria, Giovanni Felisati, Carlotta Pipolo
PURPOSE: Nowadays, several efficacious biologic drugs are used for severe asthma with or without chronic rhinosinusitis with nasal polyps (CRSwNP). However, it has been observed that not all comorbid patients (asthma/CRSwNP) receiving biologic treatment for asthma experience satisfactory control of both conditions equally. METHODS: We selected 20 patients who had both severe asthma and comorbid CRSwNP under biological treatment with benralizumab, omalizumab or mepolizumab with adequate control of asthma but inadequate control of nasal symptoms...
February 12, 2024: European Archives of Oto-rhino-laryngology